Mölnlycke Health Care breaks ground on $135M expansion of wound care manufacturing facility

BRUNSWICK, Maine, and Gothenburg, Sweden – Mölnlycke Health Care is celebrating the groundbreaking of a major expansion to its wound care manufacturing capacity in Brunswick, Maine. 

This milestone marks the beginning of a $135 million investment aimed at significantly increasing Mölnlycke’s manufacturing capacity in the United States. 

“This expansion is a bold step forward for Mölnlycke in the U.S.,” said Zlatko Rihter, CEO of Mölnlycke. “It reinforces our mission to free patients and caregivers from the burden of wounds, strengthens supply resilience, and helps us to deliver high-quality wound care solutions faster, smarter, and more sustainably. I’m proud to mark this milestone for Mölnlycke, for Maine and for the future of MedTech.” 

The expansion is part of Mölnlycke’s strategic commitment to localize production and meet growing demand from U.S. health care providers. 

The state-of-the-art facility will support Mölnlycke’s long-term sustainability goals by using renewable energy solutions, including wind and solar power, and streamlined logistics. Over the next five years, the investment will create new job opportunities, increasing Mölnlycke’s workforce in Maine by approximately 10%. 

“Today isn’t just about breaking ground. It’s about being bold, embracing partnerships and leading with passion,” said Chris Biddle, general manager of U.S. manufacturing, wound care. “Thank you to everyone who helped bring this vision to reality. The expansion is a win for Mölnlycke, for the local community and, ultimately, for the patients we serve.” 

The groundbreaking ceremony was attended by senior federal and state lawmakers, including U.S. Sen. Angus King and Maine Governor Janet Mills, who offered their support for the investment.